Loma Linda University Health performs Southern California’s first Vercise implant to treat Parkinson’s disease

0
495

Deep brain simulation procedure utilizes Boston Scientific devise

February 12, 2018

Loma Linda University Health PR Staff


Loma Linda University Health performs Southern California's first Vercise implant to treat Parkinson's disease

Loma Linda University Health is the first in Southern California to perform a Vercise implant to treat Parkinson’s disease. Khashayar Dashtipour, MD, PhD and Miguel Lopez-Gonzalez, MD, FACS performed the procedure at Loma Linda University Medical Center last week. [Photo Credit: Loma Linda University Health]

A new, innovative deep brain stimulation (DBS) system, called Vercise, was successfully implanted in an 81-year-old patient with Parkinson’s Disease at Loma Linda University Health, the first such procedure in Southern California and the fourth in the nation to utilize the DBS device to treat Parkinson’s. 

Loma Linda University Health neurologist Khashayar Dashtipour, MD, PhD, and neurosurgeon Miguel Lopez-Gonzalez, MD, FACS, performed the groundbreaking implant of the Vercise device last week.   

The procedure involves the implant of a thin wire — called a lead — into the patient’s targeted brain region. In this particular case, the patient received electrodes on each side of the brain, including the battery. Electrical stimulation is delivered via the lead, which helps control abnormal brain activity that causes tremors, stiffness or slow movement. 

“This device opens more doors for Parkinson’s patients in need of deep brain stimulation,” Lopez-Gonzalez said. “With time, we will be able to monitor the device’s progress and hopefully determine if this is more beneficial.”

In December 2017, the FDA approved the Boston Scientific device, the third approved device in the United States for performing DBS. 

The rechargeable device was first approved in Europe following various clinical trials. It has been used to increase precision and avoid common side effects of DBS therapy that affects the brain beyond the intended target. It offers a multi-source constant current, allowing flexible control of stimulation that adapts to individual physiologies, impedance variabilities, and disease progression. 

LEAVE A REPLY

Please enter your comment!
Please enter your name here